| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Operating income | NaN | 69 | NaN | NaN |
| Interest expense | NaN | 192 | NaN | NaN |
| Loss before income tax (benefit) expense and equity in net earnings of subsidiaries | NaN | -123 | NaN | NaN |
| Income tax (benefit) expense | NaN | -36 | NaN | NaN |
| Net loss before equity in net earnings of subsidiaries | NaN | -87 | NaN | NaN |
| Equity in net earnings of subsidiaries | NaN | 559 | NaN | NaN |
| Net income | 14 | -160 | 79 | 255 |
| Depreciation and amortization | 39 | 44 | 45 | 58 |
| Deferred income taxes | 30 | -6 | -15 | -9 |
| Share-based compensation | 33 | 20 | -3 | 3 |
| Impairment | 93 | NaN | NaN | NaN |
| Other, net | 0 | -1 | -2 | -2 |
| Receivables | -113 | 27 | -348 | 376 |
| Prepaid expenses and other current assets | 86 | -77 | 35 | -66 |
| Medical claims and benefits payable | 54 | 25 | -107 | 31 |
| Amounts due government agencies | 359 | -124 | -386 | -49 |
| Accounts payable, accrued liabilities and other | 79 | -26 | 106 | -33 |
| Deferred revenue | 335 | -7 | 15 | -311 |
| Income taxes | 79 | -125 | -200 | 47 |
| Net cash provided by operating activities | 1,082 | -298 | -125 | -302 |
| Purchases of investments | 249 | 144 | 186 | 232 |
| Proceeds from sales and maturities of investments | 295 | 391 | 300 | 386 |
| Net cash paid in business combinations | 0 | 0 | 0 | 0 |
| Purchases of property, equipment and capitalized software | 27 | -1 | 38 | 42 |
| Other, net | 8 | 18 | -1 | -16 |
| Net cash provided by (used in) investing activities | 11 | 230 | 77 | 128 |
| Proceeds from borrowings under credit facility and term loans | 0 | 0 | 450 | 500 |
| Repayment of credit facility and term loans | NaN | 740 | 160 | 200 |
| Common stock purchases | 0 | 0 | 500 | 0 |
| Proceeds from senior notes offerings, net of issuance costs | NaN | 838 | NaN | NaN |
| Common stock withheld to settle employee tax obligations | 14 | 0 | 1 | 0 |
| Other, net | -6 | -6 | -9 | 11 |
| Net cash (used in) provided by financing activities | -20 | 92 | -220 | -189 |
| Net increase in cash, cash equivalents, and restricted cash and cash equivalents | 1,073 | 24 | -268 | -363 |
| Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period | 4,348 | 4,324 | 4,592 | 4,955 |
| Cash, cash equivalents, and restricted cash and cash equivalents at end of period | 5,421 | 4,348 | 4,324 | 4,592 |
MOLINA HEALTHCARE, INC. (MOH)
MOLINA HEALTHCARE, INC. (MOH)